Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer diseaseEric McDade, Robert A. Koeppe, Guoqiao Wang et al.|Neurology|2018Cited by 322
The DIAN‐TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression modelRandall J. Bateman, Chengjie Xiong, Jason Hassenstab et al.|Alzheimer s & Dementia|2016Cited by 303
α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s diseaseTracy Cole, Katrina L. Paumier|JCI Insight|2021Cited by 136
Alpha-synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s diseaseTracy Cole, Katrina L. Paumier|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 10